US Stock MarketDetailed Quotes

Oruka Therapeutics (ORKA)

Watchlist
  • 32.500
  • +0.500+1.56%
Close Jan 15 15:59 ET
  • 31.850
  • -0.650-2.00%
Post 20:01 ET
1.57BMarket Cap-85.53P/E (TTM)

Oruka Therapeutics (ORKA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
15.81%34.11M
32.27%28.43M
265.53%25.09M
29.45M
21.49M
6.86M
Selling and administrative expenses
36.16%5.12M
53.97%4.34M
209.04%5.16M
--3.76M
--2.82M
--1.67M
-General and administrative expense
36.16%5.12M
53.97%4.34M
209.04%5.16M
--3.76M
--2.82M
--1.67M
Research and development costs
12.83%28.99M
28.99%24.09M
283.69%19.93M
--25.69M
--18.67M
--5.19M
Operating profit
-15.81%-34.11M
-32.27%-28.43M
-265.53%-25.09M
-29.45M
-21.49M
-6.86M
Net non-operating interest income expense
363.92%3.83M
614.27%3.86M
2,012.15%4.09M
826K
-750K
-214K
Non-operating interest income
188.12%3.83M
--3.86M
--4.09M
--1.33M
--0
--0
Non-operating interest expense
--0
--0
--0
--504K
--750K
--214K
Other net income (expense)
-4K
-2K
-5K
Other non- operating income (expenses)
---4K
---2K
---5K
----
----
----
Income before tax
-5.78%-30.28M
-10.48%-24.57M
-196.72%-21M
-28.62M
-22.24M
-7.08M
Income tax
Net income
-5.78%-30.28M
-10.48%-24.57M
-196.72%-21M
-28.62M
-22.24M
-7.08M
Net income continuous Operations
-5.78%-30.28M
-10.48%-24.57M
-196.72%-21M
---28.62M
---22.24M
---7.08M
Minority interest income
Net income attributable to the parent company
-5.78%-30.28M
-10.48%-24.57M
-196.72%-21M
-28.62M
-22.24M
-7.08M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-5.78%-30.28M
-10.48%-24.57M
-196.72%-21M
-28.62M
-22.24M
-7.08M
Basic earnings per share
62.33%-0.55
39.20%-0.46
-66.16%-0.4
-1.46
-0.7566
-0.2407
Diluted earnings per share
62.33%-0.55
39.20%-0.46
-66.16%-0.4
-1.46
-0.7566
-0.2407
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 000000
Operating revenue --0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 15.81%34.11M32.27%28.43M265.53%25.09M29.45M21.49M6.86M
Selling and administrative expenses 36.16%5.12M53.97%4.34M209.04%5.16M--3.76M--2.82M--1.67M
-General and administrative expense 36.16%5.12M53.97%4.34M209.04%5.16M--3.76M--2.82M--1.67M
Research and development costs 12.83%28.99M28.99%24.09M283.69%19.93M--25.69M--18.67M--5.19M
Operating profit -15.81%-34.11M-32.27%-28.43M-265.53%-25.09M-29.45M-21.49M-6.86M
Net non-operating interest income expense 363.92%3.83M614.27%3.86M2,012.15%4.09M826K-750K-214K
Non-operating interest income 188.12%3.83M--3.86M--4.09M--1.33M--0--0
Non-operating interest expense --0--0--0--504K--750K--214K
Other net income (expense) -4K-2K-5K
Other non- operating income (expenses) ---4K---2K---5K------------
Income before tax -5.78%-30.28M-10.48%-24.57M-196.72%-21M-28.62M-22.24M-7.08M
Income tax
Net income -5.78%-30.28M-10.48%-24.57M-196.72%-21M-28.62M-22.24M-7.08M
Net income continuous Operations -5.78%-30.28M-10.48%-24.57M-196.72%-21M---28.62M---22.24M---7.08M
Minority interest income
Net income attributable to the parent company -5.78%-30.28M-10.48%-24.57M-196.72%-21M-28.62M-22.24M-7.08M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -5.78%-30.28M-10.48%-24.57M-196.72%-21M-28.62M-22.24M-7.08M
Basic earnings per share 62.33%-0.5539.20%-0.46-66.16%-0.4-1.46-0.7566-0.2407
Diluted earnings per share 62.33%-0.5539.20%-0.46-66.16%-0.4-1.46-0.7566-0.2407
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More